SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cryoport, Inc. – ‘10-K’ for 12/31/22 – ‘EX-23.1’

On:  Tuesday, 2/28/23, at 5:08pm ET   ·   For:  12/31/22   ·   Accession #:  1410578-23-188   ·   File #:  1-34632

Previous ‘10-K’:  ‘10-K’ on 2/28/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 3/13/24 for 12/31/23   ·   27 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/23  Cryoport, Inc.                    10-K       12/31/22  119:18M                                    Toppan Merrill/FA2

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.97M 
 2: EX-21       Subsidiaries List                                   HTML     37K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     34K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     37K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     37K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     33K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     33K 
13: R1          Document and Entity Information                     HTML    100K 
14: R2          Consolidated Balance Sheets                         HTML    154K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     62K 
16: R4          Consolidated Statements of Operations               HTML    131K 
17: R5          Consolidated Statements of Comprehensive Loss       HTML     61K 
18: R6          Consolidated Statements of Stockholders' Equity     HTML    154K 
19: R7          Consolidated Statements of Stockholders' Equity     HTML     37K 
                (Parenthetical)                                                  
20: R8          Consolidated Statements of Cash Flows               HTML    174K 
21: R9          Nature of the Business                              HTML     36K 
22: R10         Summary of Significant Accounting Policies          HTML    165K 
23: R11         Acquisitions                                        HTML    138K 
24: R12         Cash, Cash Equivalents and Short-Term Investments   HTML    160K 
25: R13         Fair Value Measurements                             HTML    156K 
26: R14         Inventory                                           HTML     44K 
27: R15         Property and Equipment                              HTML     71K 
28: R16         Goodwill and Intangible Assets                      HTML    141K 
29: R17         Accrued Compensation and Related Expenses           HTML     44K 
30: R18         Convertible Senior Notes                            HTML     88K 
31: R19         Notes Payable                                       HTML     69K 
32: R20         Leases                                              HTML    122K 
33: R21         Employee Benefit Plans                              HTML     39K 
34: R22         Commitments and Contingencies                       HTML     41K 
35: R23         Stockholders' Equity                                HTML     65K 
36: R24         Stock-Based Compensation                            HTML    220K 
37: R25         Income Taxes                                        HTML    190K 
38: R26         Quarterly Financial Data                            HTML     99K 
39: R27         Summary of Significant Accounting Policies          HTML    241K 
                (Policies)                                                       
40: R28         Summary of Significant Accounting Policies          HTML    105K 
                (Tables)                                                         
41: R29         Acquisitions (Tables)                               HTML    128K 
42: R30         Cash, Cash Equivalents and Short-Term Investments   HTML    164K 
                (Tables)                                                         
43: R31         Fair Value Measurements (Tables)                    HTML    154K 
44: R32         Inventory (Tables)                                  HTML     45K 
45: R33         Property and Equipment (Tables)                     HTML     72K 
46: R34         Goodwill and Intangible Assets (Tables)             HTML    148K 
47: R35         Accrued Compensation and Related Expenses (Tables)  HTML     43K 
48: R36         Convertible Senior Notes (Tables)                   HTML     61K 
49: R37         Notes Payable (Tables)                              HTML     71K 
50: R38         Leases (Tables)                                     HTML    125K 
51: R39         Stockholders' Equity (Tables)                       HTML     39K 
52: R40         Stock-Based Compensation (Tables)                   HTML    226K 
53: R41         Income Taxes (Tables)                               HTML    190K 
54: R42         Quarterly Financial Data (Tables)                   HTML     98K 
55: R43         Summary of Significant Accounting Policies -        HTML     55K 
                Disaggregates Our Revenues by Major Source                       
                (Details)                                                        
56: R44         Summary of Significant Accounting Policies -        HTML     52K 
                Disaggregation Our Geographical Revenues by Origin               
                (Details)                                                        
57: R45         Summary of Significant Accounting Policies - Basic  HTML     75K 
                and Diluted Net Loss Per Share (Details)                         
58: R46         Summary of Significant Accounting Policies -        HTML     44K 
                Antidilutive shares (Details)                                    
59: R47         Summary of Significant Accounting Policies -        HTML    170K 
                Additional information (Details)                                 
60: R48         Acquisition - Additional information (Details)      HTML    115K 
61: R49         Acquisitions - Allocation of purchase price         HTML    104K 
                (Details)                                                        
62: R50         Acquisition - Preliminary Fair Value of Intangible  HTML     76K 
                Assets (Details)                                                 
63: R51         Cash, Cash Equivalents and Short-Term Investments   HTML     58K 
                (Details)                                                        
64: R52         Cash, Cash Equivalents and Short-Term Investments   HTML     44K 
                - Available-for-sale Investments (Details)                       
65: R53         Cash, Cash Equivalents and Short-term Investments   HTML     52K 
                - Contractual Maturities (Details)                               
66: R54         Cash, Cash Equivalents and Short-Term Investments   HTML     57K 
                - Company's gross unrealized losses and fair value               
                (Details)                                                        
67: R55         Cash, Cash Equivalents and Short-Term Investments   HTML     41K 
                - Equity Investments (Details)                                   
68: R56         Fair Value Measurements - Fair value hierarchy      HTML     64K 
                (Details)                                                        
69: R57         Fair Value Measurements - Estimated fair values     HTML     40K 
                and the carrying values (Details)                                
70: R58         Fair Value Measurements - losses recognized in      HTML     50K 
                earnings and the change in net asset - (Details)                 
71: R59         Fair Value Measurements - Additional Information    HTML     38K 
                (Details)                                                        
72: R60         Inventory (Details)                                 HTML     39K 
73: R61         Property and Equipment (Details)                    HTML     59K 
74: R62         Property and Equipment - Geographic information     HTML     38K 
                (Details)                                                        
75: R63         Property and Equipment - Additional information     HTML     38K 
                (Details)                                                        
76: R64         Goodwill and Intangible Assets - Schedule of        HTML     51K 
                goodwill (Details)                                               
77: R65         Goodwill and Intangible Assets - Intangible Assets  HTML     66K 
                (Details)                                                        
78: R66         Goodwill and Intangible Assets - Expected future    HTML     46K 
                amortization (Details)                                           
79: R67         Goodwill and Intangible Assets - Additional         HTML     34K 
                Information (Details)                                            
80: R68         Accrued Compensation and Related Expenses           HTML     38K 
                (Details)                                                        
81: R69         Convertible Senior Notes - Components of            HTML     43K 
                Convertible notes payable (Details)                              
82: R70         Convertible Senior Notes - Interest expenses        HTML     40K 
                incurred on Convertible notes payable (Details)                  
83: R71         Convertible Senior Notes - Additional information   HTML    118K 
                (Details)                                                        
84: R72         Notes Payable (Details)                             HTML     53K 
85: R73         Notes Payable - Interest expense (Details)          HTML     43K 
86: R74         Notes Payable - Future note payments (Details)      HTML     52K 
87: R75         Note Payable - Additional information (Details)     HTML     54K 
88: R76         Leases - Components Of Lease Cost (Details)         HTML     44K 
89: R77         Leases - Supplemental Cash Flows Information        HTML     58K 
                (Details)                                                        
90: R78         Leases - Future Payments Under Non-Cancellable      HTML     74K 
                Leases (Details)                                                 
91: R79         Leases - Additional Information (Details)           HTML     44K 
92: R80         Employee Benefit Plans (Details)                    HTML     46K 
93: R81         Commitments and Contingencies (Details)             HTML     38K 
94: R82         Stockholders' Equity - Authorized Stock (Details)   HTML     50K 
95: R83         Stockholders' Equity - Common Stock Issuances For   HTML     39K 
                Services (Details)                                               
96: R84         Stockholders' Equity - Repurchase Program           HTML     40K 
                (Details)                                                        
97: R85         Stockholders' Equity - November 2021 Registered     HTML     49K 
                Direct Placement and Stock Purchase Agreements                   
                (Details)                                                        
98: R86         Stockholders' Equity - January 2021 Public          HTML     42K 
                Offering (Details)                                               
99: R87         Stockholders' Equity - Blackstone Private           HTML    115K 
                Placement and Conversion (Details)                               
100: R88         Stockholders' Equity - Common Stock Reserved for    HTML     47K  
                Future Issuance (Details)                                        
101: R89         Stock-Based Compensation - Assumptions Used to      HTML     49K  
                Estimate Fair Value of Stock Options (Details)                   
102: R90         Stock-Based Compensation - Stock-based              HTML     40K  
                Compensation Expense (Details)                                   
103: R91         Stock-Based Compensation - Stock Option Activity    HTML    101K  
                (Details)                                                        
104: R92         Stock-Based Compensation - Schedule of Stock        HTML     83K  
                Options Outstanding and Exercisable (Details)                    
105: R93         Stock-Based Compensation - Restricted stock unit    HTML     55K  
                (Details)                                                        
106: R94         Stock-Based Compensation - Additional Information   HTML     74K  
                (Details)                                                        
107: R95         Income Taxes - Loss Before Provision For Income     HTML     38K  
                Taxes (Details)                                                  
108: R96         Income Taxes - Expense For Income Taxes (Details)   HTML     61K  
109: R97         Income Taxes - Schedule of Deferred Tax Assets      HTML     72K  
                (Details)                                                        
110: R98         Income Taxes - net deferred tax liability as        HTML     39K  
                presented in consolidated balance sheet (Details)                
111: R99         Income Taxes - Schedule of Income Tax Provision     HTML     63K  
                (Details)                                                        
112: R100        Income Taxes - Schedule of unrecognized tax         HTML     41K  
                positions (Details)                                              
113: R101        Income Taxes - Additional information (Details)     HTML     47K  
114: R102        Quarterly Financial Data (Details)                  HTML     73K  
117: XML         IDEA XML File -- Filing Summary                      XML    224K  
115: XML         XBRL Instance -- cyrx-20221231x10k_htm               XML   4.83M  
116: EXCEL       IDEA Workbook of Financial Reports                  XLSX    262K  
 9: EX-101.CAL  XBRL Calculations -- cyrx-20221231_cal               XML    315K 
10: EX-101.DEF  XBRL Definitions -- cyrx-20221231_def                XML   1.05M 
11: EX-101.LAB  XBRL Labels -- cyrx-20221231_lab                     XML   2.26M 
12: EX-101.PRE  XBRL Presentations -- cyrx-20221231_pre              XML   1.63M 
 8: EX-101.SCH  XBRL Schema -- cyrx-20221231                         XSD    287K 
118: JSON        XBRL Instance as JSON Data -- MetaLinks              667±  1.08M  
119: ZIP         XBRL Zipped Folder -- 0001410578-23-000188-xbrl      Zip    989K  


‘EX-23.1’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  C:  <!  <> 

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1)

 

Registration Statement (Form S-3 No. 333-230237, 333-229395, and 333-251354) of Cryoport, Inc.;

 

(2)

 

Registration Statement (Form S-8 No. 333-225387 and 333-257368) pertaining to the 2018 Omnibus Equity Incentive Plan;

 

(3)

 

Registration Statement (Form S-8 No. 333-208381) pertaining to the 2015 Omnibus Equity Incentive Plan;

(4)

 

Registration Statement (Form S-8 No. 333-177168, 333-184543, and 333-197437) pertaining to the 2011 Stock Incentive Plan;

of our reports dated February 28, 2023, with respect to the consolidated financial statements of Cryoport, Inc. and the effectiveness of internal control over financial reporting of Cryoport, Inc. included in this Annual Report (Form 10-K) of Cryoport, Inc. for the year ended December 31, 2022.

/s/ Ernst & Young LLP

Irvine, California
February 28, 2023

Guidance:



Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/28/23None on these Dates
For Period end:12/31/22
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/21/23  Cryoport, Inc.                    424B3                  1:533K                                   Toppan Merrill/FA
12/15/23  Cryoport, Inc.                    POS AM                 2:866K                                   Toppan Merrill/FA
12/15/23  Cryoport, Inc.                    POSASR     12/15/23    6:967K                                   Toppan Merrill/FA


24 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/21/22  Cryoport, Inc.                    8-K:5,9     3/15/22   12:430K                                   Toppan Merrill/FA
11/12/21  Cryoport, Inc.                    8-K:1,2,3,911/12/21   12:1.1M                                   Toppan Merrill/FA
 5/05/21  Cryoport, Inc.                    8-K:5,9     4/30/21   11:369K                                   Toppan Merrill/FA
 3/01/21  Cryoport, Inc.                    10-K       12/31/20  112:13M                                    Toppan Merrill/FA
10/01/20  Cryoport, Inc.                    8-K:1,2,3,510/01/20   15:1M                                     Toppan Merrill/FA
 8/25/20  Cryoport, Inc.                    8-K:1,3,7,9 8/24/20   15:3.7M                                   Toppan Merrill/FA
 8/21/20  Cryoport, Inc.                    8-K:1,7,9   8/21/20   13:706K                                   Toppan Merrill/FA
 5/27/20  Cryoport, Inc.                    8-K:1,2,3,9 5/26/20    3:806K                                   Toppan Merrill/FA
10/30/19  Cryoport, Inc.                    8-K:5,9    10/28/19    3:106K                                   Toppan Merrill/FA
 5/14/19  Cryoport, Inc.                    8-K:1,2,7,9 5/14/19    3:454K                                   Toppan Merrill/FA
 3/13/19  Cryoport, Inc.                    10-K       12/31/18   92:10M                                    Toppan Merrill/FA
 4/03/18  Cryoport, Inc.                    8-K:5,9     3/28/18    2:52K                                    Toppan Merrill/FA
 5/31/17  Cryoport, Inc.                    8-K:5,9     5/26/17    2:109K                                   Toppan Merrill/FA
 2/08/16  Cryoport, Inc.                    8-K:2,5,8,9 2/08/16    3:218K                                   Toppan Merrill/FA
12/01/15  Cryoport, Inc.                    8-K:5,9    11/23/15    2:334K                                   Toppan Merrill/FA
10/01/15  Cryoport, Inc.                    DEF 14A    10/28/15    1:491K                                   Toppan Merrill/FA
 9/04/15  Cryoport, Inc.                    8-K:3,5,9   9/01/15    3:1.5M                                   Toppan Merrill/FA
 6/22/15  Cryoport, Inc.                    S-1/A                  6:7.7M                                   Toppan Merrill/FA
 5/19/15  Cryoport, Inc.                    10-K        3/31/15   82:9.4M                                   Toppan Merrill/FA
 4/17/15  Cryoport, Inc.                    S-1/A                 84:12M                                    Toppan Merrill/FA
 3/30/15  Cryoport, Inc.                    8-K:3,5,9   3/26/15    2:452K                                   Toppan Merrill/FA
 2/20/15  Cryoport, Inc.                    8-K:1,2,3,5 2/17/15    4:217K                                   Toppan Merrill/FA
11/09/12  Cryoport, Inc.                    10-Q        9/30/12   47:3.4M                                   Donnelley … Solutions/FA
 8/15/11  Cryoport, Inc.                    DEF 14A     9/22/11    1:314K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001410578-23-000188   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 7, 11:52:46.3pm ET